Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/253.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Bordetella (e.g., bordetella bronchiseptica, etc.)
Description: Subject matter wherein the bacterium is of the genus Bordetella.


Sub-classes under this class:

Class Number Class Name Patents
424/254.1 Bordetella pertussis 95


Patents under this class:
1 2

Patent Number Title Of Patent Date Issued
7285289 Nanoparticle vaccines Oct. 23, 2007
7211263 Use of adenylate cyclase or bacteria producing it as vaccines against Bordetella May. 1, 2007
RE39494 Inactivated mycoplasma hyopneumoniae and uses therefor Feb. 27, 2007
7105317 Immunogenic compositions comprising vrg-gene products from Bordetella extracts Sep. 12, 2006
7087236 Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof Aug. 8, 2006
7070779 POLYPEPTIDES CONTAINING POLYMORPHISMS OF THE REPEATED REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS, AND BORDETELLA BRONCHISEPTICA, THEIR USE IN DIAGNOSTICS, AND IN IM Jul. 4, 2006
7029678 Vaccines Apr. 18, 2006
6964767 POLYPEPTIDES CONTAINING POLYMORPHISMS OF THE REPEATED REGIONS OF PERTACTIN IN BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS, AND BORDETELLA BRONCHISEPTICA, THEIR USE IN DIAGNOSTICS, AND IN IM Nov. 15, 2005
6929794 IL-12 as an adjuvant for Bordetella pertussis vaccines Aug. 16, 2005
6905691 Vaccines containing attenuated bacteria Jun. 14, 2005
6814971 Adjuvants for use in vaccines Nov. 9, 2004
6696065 Acellular pertussis vaccines and methods of preparation thereof Feb. 24, 2004
6623739 Vaccines Sep. 23, 2003
6585981 Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae Jul. 1, 2003
6582705 Acellular antibordetella vaccine Jun. 24, 2003
6562352 Vaccine compositions for mucosal delivery May. 13, 2003
6548287 Non-pyrogenic bacterial strains and use of the same Apr. 15, 2003
6517844 Compositions and method for immunizing polutry Feb. 11, 2003
6444211 Purification of a pertussis outer membrane protein Sep. 3, 2002
6387377 Acellular antibordetella vaccine May. 14, 2002
6368589 Use of autologous promoters to express gene products in Bordetella Apr. 9, 2002
6309648 Protective epitopes of adenyl cyclase-haemolysin (AC-Hly), their application to the treatment or to the prevention of bordetella infections Oct. 30, 2001
6284256 Bordetella bronchiseptica vaccine Sep. 4, 2001
6214356 Use of adenylate cyclase or bacteria producing it as vaccines against bordetella Apr. 10, 2001
6210685 Antigenic preparations and isolation of such preparations Apr. 3, 2001
6156322 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy Dec. 5, 2000
6146632 Vaccines Nov. 14, 2000
6127151 Antigenic preparations and the isolation of such preparations Oct. 3, 2000
6060067 Process for the preparation of tetanus toxoid vaccine May. 9, 2000
6036960 Filamentous hemagglutinin of B. pertussis Mar. 14, 2000
6030625 Bordetella pertussis and Bordetella parapertussis strains Feb. 29, 2000
5997881 Method of making non-pyrogenic lipopolysaccharide or A Dec. 7, 1999
5985286 Bordetella strains Nov. 16, 1999
5980907 Vaccines containing bacteria attenuated by mutation of the htrA gene Nov. 9, 1999
5976544 Polypeptides and vaccines for Bordetellapertussis and method of use Nov. 2, 1999
5968525 Inactivated Mycolplasma hyopneumoniae and uses therefor Oct. 19, 1999
5935580 Recombinant mutants for inducing specific immune responses Aug. 10, 1999
5932217 Peptides which inhibit adhesion between leukocytes and endothelial cells Aug. 3, 1999
5897867 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens Apr. 27, 1999
5895655 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens Apr. 20, 1999
5885586 Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens Mar. 23, 1999
5885587 Efficacious vaccines against Bordetella pertussis comprising a combination of individually purified pertussis antigens Mar. 23, 1999
5804198 Vaccines against disease caused by pathogenic pilus-forming bacteria Sep. 8, 1998
5798103 Whooping cough vaccine comprising a fimbria protein Aug. 25, 1998
5695769 Pasteurella multocida toxoid vaccines Dec. 9, 1997
5667787 Purification of a pertussis outer membrane protein Sep. 16, 1997
5648080 Antigenic preparations and isolation of such preparations Jul. 15, 1997
5643753 Use of autologous promoters to express gene products in bordetella Jul. 1, 1997
5622706 Cloning and sequencing of the gene which codes for a new pilinic subunit of bordella pertussis Apr. 22, 1997
5595744 Respiratory disease vaccine for cats Jan. 21, 1997

1 2


 
 
  Recently Added Patents
Television receiver
Plunger pot
Method for joining at least two plate-shaped workpieces
Anti-unplugging unit and transmission cord
Gaming device having a bonus scheme with alternative ending sequences
Fork
Glucoamylase variants
  Randomly Featured Patents
Guitar pickup structure using vibration transmitting bars
Liquid crystal display device having light guide with refractive surface
Faucet set
Powdered mixture of polyamides for heat sealing by the powder point process
Electro-photographic copier with anti-spill arrangement
Particulate solids cracking apparatus
Micro-structures having structural members capable of withstanding permanent bend
Telescopic and illuminative device
Line deflection circuit in a picture display device
Carousel conveyor with rotatable storage racks